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CASE PRESENTATION
A 73-year-old male exsmoker with Global initiative for chronic Obstructive Lung Disease (GOLD) stage III chronic obstructive 
pulmonary disease (COPD) underwent airway bypass (AB) in February 
2009 as part of the Exhale Airway Stents for Emphysema (EASE) trial. 
Thirty-two months before AB (June 2006), he reported a 70 pack-year 
smoking history, having ceased smoking approximately 13 years ear-
lier, and was enrolled in a longitudinal hyperpolarized 3He magnetic 
resonance imaging (MRI) study. At the initial study visit 32 months 
pre-AB, his measured forced expiratory volume in 1 s (FEV1) was 1.2 L 
(32% predicted); all other measured parameters are presented in Table 1. 
Hyperpolarized 3He MRI was performed at 3.0 Tesla using a fast-
gradient recalled echo-pulse sequence for static ventilation imaging as 
previously described (1-3). Images were acquired with the subject in 
breath-hold, after inspiration of 1.0 L of 5 mL/kg 3He mixed with 
nitrogen gas from functional residual capacity. Proton MRI of the 
thorax was also acquired as previously described (4) within 3 min of 
3He MRI, with the same breath-hold volume to obtain a structural 
image of the thorax that enabled clear delineation of the thoracic cav-
ity. This MRI approach has been previously used in acute COPD 
therapy (5) and longitudinal studies (6). MRI reproducibility in 
COPD was also previously evaluated at the Imaging Research 
Laboratories, Robarts Research Institute (London, Ontario) (1) and 
elsewhere (7,8), and was high, supporting its use in serial studies. In 
Figure 1, 3He MRI performed at 32 months pre-AB (top left panel), 
shows heterogeneous distribution of gas with large ventilation defects 
and regionally heterogeneous 3He MR signal intensity characteris-
tic of COPD. On returning for follow-up imaging 24 months later 
(eight months pre-AB [Figure 1, top right panel]), 3He MRI showed 
a decrease in ventilation of the right upper and lower, and left upper 
lung regions as well as a decreased signal-to-noise ratio. Quantitative 
analysis (9) revealed a ventilation volume (VV) decrease of 3.8 L over 
the two-year period, and a corresponding decrease in per cent venti-
lated volume (PVV) from 73% to 26%. The functional imaging chan-
ges observed were coincident with a large decrease in forced vital 
capacity (FVC), and small decreases in FEV1 and inspiratory capacity 
(Table 1). There were no exacerbations or hospitalizations reported 
during this 24-month period.
At this time, the subject was enrolled in a randomized double-blind 
study evaluating the safety and efficacy of AB in subjects with homo-
geneous emphysema and severe hyperinflation. Clinical trial primary 
end points consisted of the change in the modified Medical Research 
Council scale (∆mMRC) ≥1 and ∆FVC ≥12% predicted. As part of 
the EASE protocol, he underwent six weeks of pulmonary rehabilita-
tion before AB. In February 2009, four stents were placed: two in the 
right lower and two in the left upper lung. EASE trial follow-up 
occurred one, three, six and 12 months poststenting, with 3He MRI at 
the six- and 12-month post-AB time points. At six months post-AB, 
his FVC increased by 8% predicted; he was, therefore, categorized as 
an AB nonresponder. In contrast, at six months post-AB, visually 
obvious changes in the 3He MRI gas distribution that generally cor-
respond to stent placement were observed throughout the right lung 
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A 73-year-old exsmoker with Global initiative for chronic Obstructive 
Lung Disease stage III chronic obstructive pulmonary disease underwent 
airway bypass (AB) as part of the Exhale Airway Stents for Emphysema 
(EASE) trial, and was the only EASE subject to undergo hyperpolarized 
3He magnetic resonance imaging for evaluation of lung function pre- and 
post-AB. 3He magnetic resonance imaging was acquired twice previously 
(32 and eight months pre-AB) and twice post-AB (six and 12 months post-
AB). Six months post-AB, his increase in forced vital capacity was <12% 
predicted, and he was classified as an AB nonresponder. However, post-
AB, he also demonstrated improvements in quality of life scores, 6 min 
walk distance and improvements in 3He gas distribution in the regions of 
stent placement. Given the complex relationship between well-established 
pulmonary function and quality of life measurements, the present case 
provides evidence of the value-added information functional imaging may 
provide in chronic obstructive pulmonary disease interventional studies. 
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L’imagerie par résonance magnétique fonctionnelle 
par 3He hyperpolarisé de la dérivation des voies 
respiratoires par bronchoscopie en cas de maladie 
pulmonaire obstructive chronique
Un ex-fumeur de 73 ans atteint d’une maladie pulmonaire obstructive 
chronique de phase III d’après la Global Initiative for Chronic Obstructive 
Lung Disease a subi une dérivation des voies respiratoires (DVR) dans le 
cadre de l’essai EASE sur les endoprothèses des voies respiratoires par 
expiration et était le seul sujet de l’essai EASE à subir une imagerie par 
résonance magnétique (IRM) par 3He hyperpolarisé pour évaluer la fonc-
tion pulmonaire avant et après la DVR. Il avait subi une IRM par 3He 
deux fois auparavant (32 mois et huit mois avant la DVR) et deux fois 
après la DVR (six et 12 mois après). Six mois après la DVR, l’augmentation 
de sa capacité vitale forcée était de 12 % inférieure aux valeurs prévues, et 
il avait été classé comme ne répondant pas à la DVR. Cependant, après la 
DVR, il a également présenté des améliorations aux indices de qualité de 
vie, au test de marche de 6 minutes et des améliorations de la distribution 
de gaz par 3He dans les foyers d’installation des endoprothèses. Étant 
donné le lien complexe entre la fonction pulmonaire bien établie et les 
mesures de qualité de vie, ce cas démontre l’information à valeur ajoutée 
que peut fournir l’imagerie fonctionnelle dans le cadre d’études 
d’intervention sur les maladies pulmonaires obstructives chroniques.
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and in the left upper lobe (Figure 1, lower left panel) with further 
improvements, specifically in the right lower lung observed 12 months 
post-AB (Figure 1, lower right panel). The visually apparent ventila-
tion improvements in the right lower and left upper lobes were in the 
same regions where stents were originally placed. There were also 
other areas of regionally improved gas distribution (arrows), and all of 
these visually apparent changes in gas distribution corresponded to 
3He MRI VV increases of 3.2 L at six months and 4.2 L at 12 months 
post-AB. At the same time, other surrogate measures of functional 
capacity including 6 min walk distance (6MWD), the St George’s 
Respiratory Questionnaire (SGRQ) score and cycle ergometry time 
showed improvements six months post-AB (6MWD increased by 78 m, 
SGRQ score decreased by 38 and cycle ergometry time improved by 
334 s). Along with improvements in quality of life measures, the dif-
fusing capacity of carbon monoxide (DLCO) nearly doubled between 
the pre-AB and 12-month post-AB time points (Table 1).  
DISCUSSION
AB is an investigational procedure that involves the creation of extra-
anatomical passages reinforced by a drug-eluting stent in the airway 
wall, with stents delivered using Doppler-guidance to avoid pulmonary 
vasculature in airway regions where the stents are inserted. The aim of 
AB is to artificially connect the segmental airways to adjacent lung 
tissue, thereby allowing trapped gas to be exhaled. Bronchoscopic lung 
volume reduction methods, such as AB, provide a minimally invasive 
alternative to lung volume reduction surgery with the goal of improving 
COPD quality of life, pulmonary function and survival (10-12). 
Unfortunately, for many of these approaches, significant improve-
ments in intermediate end points such as FEV1 and residual volume/
total lung capacity have not been realized postintervention (13-15) 
and, occasionally, these results are discordant with symptomatic or 
other functional improvements.  
Figure 1) 3He magnetic resonance (MR) ventilation image of a Global initiative 
for chronic Obstructive Lung Disease (GOLD) stage III chronic obstructive pul-
monary disease exsmoker 32 months before airway bypass (AB) (top left panel): 
forced expiratory volume in 1 s (FEV1) = 32% predicted, forced vital capacity 
(FVC) = 66% predicted, and eight months before AB (top right panel), FEV1 = 
23% predicted, FVC = 49% predicted. Heterogeneous 3He signal intensity and 
large ventilation defects are visualized in both scans, with 3He MR ventilated 
volume decreased by 3.8 L during this two-year time period. In February 2009, 
two stents were inserted into the left upper lung and two into the right lower lung, 
with 3He MRI acquired six months post-AB (lower left panel): FEV1 = 33% 
predicted, FVC = 76% predicted; and 12 months post-AB (lower right panel), 
FEV1 = 35% predicted, FVC = 81% predicted. Improved gas distribution post-
AB is suggested with new regions of 3He ventilation and increased 3He signal 
intensity, and ventilated volume at both time points post-AB.
Table 1
Pulmonary function and 3He magnetic resonance imaging measurements pre- and post-airway bypass
Months
Pre-airway bypass Post-airway bypass
32 8 2 0.1 1 3 6 12
FEV1, L 1.2 0.8 0.9 1.1 1.2 1.2 1.1 1.2
FEV1, % predicted 32 23 27 32 34 35 33 35
FVC, L 3.2 2.3 2.6 3.2 3.6 3.6 3.5 3.8
FVC, % predicted 66 49 57 68 77 78 76 81
FEV1/FVC, % 37 34 35 35 32 33 32 31
RV, L 5.2 5.2 5.6 4.4 5.0 4.5 4.7 5.0
RV, % predicted 193 200 213 169 190 169 169 189
TLC, L 8.4 8.0 8.6 7.8 8.2 8.2 8.3 8.5
TLC, % predicted 111 107 115 104 114 110 108 114
RV/TLC 0.62 0.65 0.65 0.57 0.60 0.55 0.56 0.58
IC, L 1.8 1.6 1.6 2.1 2.3 2.3 1.8 2.8
DLCO, mL/min/mmHg – – 9.2 9.9 14.6 16.9 14.6 18.7
DLCO, % predicted – – 26 28 42 48 42 53
mMRC – – – 2 1 0 1 1
6MWD, m – – – 288 315 330 366 330
SGRQ – – – 65 27 27 27 31
CE, s – – – 750 – – 1084 –
WL TCV, L 7.3 6.3 – – – – 8.5 8.1
WL VV, L 5.4 1.6 – – – – 4.8 5.8
WL PVV, % 73 26 – – – – 57 72
WL VDV, L 2.0 4.7 – – – – 3.6 2.4
WL VDP, % 27 74 – – – – 43 28
6MWD 6 min walk distance; CE Cycle ergometry; DLCO Carbon monoxide diffusion capacity of the lung; FEV1 Forced expiratory volume in 1 s; FVC Forced vital 
capacity; IC Inspiratory capacity; mMRC Modified Medical Research Council; PVV Per cent ventilated volume; RV Residual volume; SGRQ St George’s Research 
Questionnaire; TCV Thoracic cavity volume; TLC Total lung capacity; VDP Ventilation defect per cent; VDV Ventilation defect volume; VV Ventilated volume; WL 
Whole lung
3He MRI of airway bypass in COPD
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We highlighted hyperpolarized 3He MRI in a single case of COPD 
in an exsmoker who underwent AB. Results of pulmonary function 
tests and 3He MRI suggest a decline in lung function over the pre-AB, 
two-year time period. Post-AB however, significant improvements in 
gas distribution were visually and quantitatively apparent after six 
months and 12 months, including increases in VV and PVV. Regional 
changes in ventilation were visualized throughout the lung, even in 
regions not associated with stent placement, perhaps due to redistribu-
tion of ventilation following the release of trapped gas. It is worth 
noting that the most visually prominent changes occurred in the right 
lower and left upper lobes – the same regions where stents were origin-
ally placed. The resultant changes in VV and PVV were much greater 
than the smallest detectable difference previously estimated for 3He 
MRI (5) based on a reproducibility study in COPD. Although 3He 
MRI was not available immediately preceding AB, which would have 
enabled identification of ventilation improvements that were due to 
stent placement alone, the imaging results obtained provided functional 
information that was in agreement with 6MWD, SGRQ and mMRC, as 
well as DLCO, but not with spirometry and plethysmography measure-
ments. Perhaps unexpectedly, both DLCO and PVV continued to 
increase post-AB, evidenced by large changes between six- and 
12-month post-AB time points. These relatively late changes post-AB 
suggest continued improvements in gas distribution post-AB that 
coincided with improved gas transfer. The intriguing coincidence of 
improved 3He gas distribution, DLCO and quality of life measures that 
endured 12 months post-AB in the only EASE trial subject for whom 
3He MRI was performed certainly generates new hypotheses to test – 
especially with respect to the use of imaging to guide stent placement 
and track regional changes in lung function.  
The high cost and limited availability of 3He MRI prohibits its 
prospective routine use in clinical research and its translation to clin-
ical practice (16). However, its high short-term reproducibility (1) and 
sensitivity (5,6), coupled with the intriguing findings in longitudinal 
(6) and other acute COPD therapy studies (5), suggest that hyperpol-
arized noble gas imaging may be an ideal tool for visualization and 
quantitative evaluation of functional differences in COPD post-
therapeutic intervention. The results of the present case study high-
light the advantage of including functional MRI techniques such as 
hyperpolarized 129Xe MRI (17,18) or conventional 1H MRI (19) in 
COPD interventional studies, and suggest the application of these 
types of imaging in interventional studies may offer new insights into 
regional physiological changes in COPD following treatment. 
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